Cargando…
QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) has been described as an independent risk factor for the development of cardiovascular (CV) disease. Since the QRESEARCH risk estimator version 3 (QRISK3) calculator was recently proposed to assess CV in the general population, our objective was to compare the predic...
Autores principales: | Carrillo-Palau, Marta, Hernández-Camba, Alejandro, Ramos, Laura, Vela, Milagros, Arranz, Laura, Hernández Alvarez-Buylla, Noemi, Alonso-Abreu, Inmaculada, Hernández-Pérez, Anjara, Hernández-Guerra, Manuel, Palazuelos, Camilo, Llorca, Javier, González-Gay, Miguel Á., Ferraz-Amaro, Iván |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464851/ https://www.ncbi.nlm.nih.gov/pubmed/34575213 http://dx.doi.org/10.3390/jcm10184102 |
Ejemplares similares
-
Carotid Plaque Assessment Reclassifies Patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk
por: Hernández-Camba, Alejandro, et al.
Publicado: (2021) -
Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease
por: Carrillo-Palau, Marta, et al.
Publicado: (2021) -
Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease
por: Hernández-Camba, Alejandro, et al.
Publicado: (2022) -
Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease
por: Rodríguez-Hernández, Orvelindo, et al.
Publicado: (2023) -
COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire
por: Ramos, Laura, et al.
Publicado: (2023)